Description
HER2/neu (869-877) is a peptide fragment of the HER2/neu receptor, also known as CD340, EGFR2, or erbB2. This receptor exhibits anti-apoptotic activity and is associated with breast and other cancers.
| Product Unit Size | Cost | Quantity | Stock |
|---|
HER2/neu (869-877) is a peptide fragment of the HER2/neu receptor, also known as CD340, EGFR2, or erbB2. This receptor exhibits anti-apoptotic activity and is associated with breast and other cancers.
| Purity | ≥95% |
|---|---|
| Formula | C49H75N9O20 |
| Formula Wt. | 1110.19 |
| Synonym | ErbB2, EGFR2 |
| Solubility | Soluble in water. |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| Info Sheet |
|---|
Mitri Z, Constantine T, O'Regan R. The HER2 Receptor in Breast Cancer: Pathophysiology, Clinical Use, and New Advances in Therapy. Chemother Res Pract. 2012;2012:743193. PMID: 23320171.
Roy V, Perez EA. Beyond trastuzumab: small molecule tyrosine kinase inhibitors in HER-2-positive breast cancer. Oncologist. 2009 Nov;14(11):1061-9. PMID: 19887469.
Abl (T315I) inhibitor.
PP2A activator, Sphk1 and PKC inhibitor.
Selective estrogen receptor modulator.
p53 inhibitor
Diarylether; bacterial ENR binder, fatty acid s...
Chaetocin is naturally produced by Chaetomium s...
SERT inhibitor, potential voltage-gated K+ chan...
Cysteine-ITC conjugate, antioxidant.
Endogenous pterin coenzyme required for release...
Bisaniline pyrimidine; pan-kinase inhibitor.
Found in Ginkgo; HIV protease and fatty acid sy...
Inhibitor of ALK2, ALK3, ALK6, and AMPK.
Serum response factor inhibitor and MRTF-A bind...
Tetracycline; protein translation inhibitor, MM...
Azoxanthone derivative; S100A12 and S100A13 inh...
Cyclic peptide mycotoxin produced by Alternaria...
Macrolide; protein translation inhibitor, mamma...
AMPA positive allosteric modulator, D2, 5-HT2A,...
VEGFR, PDGFR, c-Kit inhibitor.